WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017069610) METHOD FOR IMPROVING EQUILIBRIOCEPTION IN HEALTHY INDIVIDUALS AND NUTRITIONAL COMPOSITION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/069610    International Application No.:    PCT/NL2015/050736
Publication Date: 27.04.2017 International Filing Date: 23.10.2015
IPC:
A61K 31/198 (2006.01), A61K 31/202 (2006.01), A61K 31/7068 (2006.01), A61K 31/7072 (2006.01), A23L 33/12 (2016.01), A23L 33/13 (2016.01), A23L 33/175 (2016.01)
Applicants: N.V. NUTRICIA [NL/NL]; Eerste Stationsstraat 186 NL-2712 HM Zoetermeer (NL)
Inventors: DE WILDE, Mattheus Cornelis; (NL).
COURNOTTE, Danielle Stefanie; (NL)
Agent: NEDERLANDSCH OCTROOIBUREAU; P.O. Box 29720 NL-2502 LS The Hague (NL)
Priority Data:
Title (EN) METHOD FOR IMPROVING EQUILIBRIOCEPTION IN HEALTHY INDIVIDUALS AND NUTRITIONAL COMPOSITION
(FR) PROCÉDÉ D’AMÉLIORATION DE L’ÉQUILIBRIOCEPTION CHEZ DES INDIVIDUS SAINS ET COMPOSITION NUTRITIONNELLE
Abstract: front page image
(EN)The invention pertains to a method for improving or promotingequilibrioceptionor coordination and balancein a healthy subject, comprising administration of: (i) ω-3 polyunsaturated fatty acid (LCPUFA) selected from the group consisting of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA); (ii) one of more of uridine, cytidine and/or an equivalent thereof, including salts, phosphates, acyl derivatives and/or esters; and (iii) free leucine, to said healthy subject. The invention also pertains to a composition for use in such a method.
(FR)L’invention concerne un procédé permettant d’améliorer ou de favoriser l’équilibrioception ou la coordination et l’équilibre chez un sujet sain, comprenant l’administration : (i) d’acides gras polyinsaturés ω-3 (LCPUFA) choisis parmi le groupe constitué par l’acide docosahexaénoïque (DHA), l'acide eicosapentaénoïque (EPA) et l’acide docosapentaénoïque (DPA) ; (ii) d’un ou de plusieurs constituants parmi l’uridine, la cytidine et/ou des équivalents de ceux-ci, y compris des sels, des phosphates, des dérivés acyle et/ou des esters ; et (iii) de leucine libre, audit sujet sain. L’invention concerne également une composition destinée à être utilisée dans un tel procédé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)